Physiologic Basis for Hormonal Therapy in Carcinoma of the Prostate
- 1 February 1975
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 2 (1), 125-140
- https://doi.org/10.1016/s0094-0143(21)01062-4
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Current Status of Bilateral Adrenalectomy or Advanced Prostatic CarcinomaAnnals of Surgery, 1974
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973
- A difference in theSteroids, 1973
- EFFECTS OF SYNTHETIC ORAL OESTROGENS IN NORMAL MEN AND PATIENTS WITH PROSTATIC CARCINOMA: LACK OF GONADOTROPHIN SUPPRESSION BY CHLOROTRIANISENEClinical Endocrinology, 1973
- The Effect of Androgenic Hormones on the Reduced Nicotinamide Adenine Dinucleotide Phosphate: Δ4-3-Ketosteroid 5α-Oxidoreductase of Rat Ventral Prostate*Endocrinology, 1973
- Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic CarcinomaBMJ, 1971
- The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5α-androstanediolsJournal of Clinical Investigation, 1971
- Dihydrotestosterone in prostatic hypertrophyJournal of Clinical Investigation, 1970
- The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissueSteroids, 1970
- Selective Retention of Dihydrotestosterone by Prostatic NucleiNature, 1968